Fujian Wanchen Biotechnology Co. Ltd300972
▲ PositiveCapitalrelevance
H1 net profit up 156.58% YoY to 1.21 billion yuan with revenue up 54.26%, plus a cash dividend plan.
Impact on stocks 1
Others
Fujian Wanchen Biotechnology Co. LtdWanchen Group released its 2026 semi-annual report, achieving operating revenue of 34.836 billion yuan, up 54.26% year on year; net profit attributable to shareholders of the listed company was 1.21 billion yuan, up 156.58% year on year. The company plans to distribute a cash dividend of 0.15 yuan per 10 shares, tax included. Based on calculations, the company's second-quarter net profit was 580 million yuan, compared with 630 million yuan in the first quarter, a quarter-on-quarter decline of 7%.
Fujian Wanchen Biotechnology Co. LtdH1 net profit up 156.58% YoY to 1.21 billion yuan with revenue up 54.26%, plus a cash dividend plan.